FGFR1OP2 抗体 (AA 51-150)
Quick Overview for FGFR1OP2 抗体 (AA 51-150) (ABIN1388004)
抗原
See all FGFR1OP2 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 51-150
-
预测反应
- Human,Mouse,Rat,Dog,Horse,Rabbit
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human FGFR1OP2
-
亚型
- IgG
-
-
anti-FGFR1 Oncogene Partner 2 (FGFR1OP2) (AA 62-169) antibody
FGFR1OP2 适用: 人 ELISA, WB 宿主: 小鼠 Monoclonal 2G4 unconjugated
anti-FGFR1 Oncogene Partner 2 (FGFR1OP2) antibodyFGFR1OP2 适用: 人, 小鼠 WB, FACS 宿主: 小鼠 Monoclonal 5C4 unconjugated
anti-FGFR1 Oncogene Partner 2 (FGFR1OP2) (AA 1-172) antibodyFGFR1OP2 适用: 人 ELISA, WB 宿主: 兔 Polyclonal unconjugated
anti-FGFR1 Oncogene Partner 2 (FGFR1OP2) antibodyFGFR1OP2 适用: 人, 小鼠, 大鼠 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-FGFR1 Oncogene Partner 2 (FGFR1OP2) (AA 1-172) antibodyFGFR1OP2 适用: 人, 小鼠 WB 宿主: 小鼠 Monoclonal 1675CT713-89-84 unconjugated
anti-FGFR1 Oncogene Partner 2 (FGFR1OP2) (AA 62-169) antibodyFGFR1OP2 适用: 人 ELISA, WB 宿主: 小鼠 Polyclonal unconjugated
-
-
应用备注
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
有效期
- 12 months
-
-
- FGFR1OP2 (FGFR1 Oncogene Partner 2 (FGFR1OP2))
-
别名
- FGFR1OP2
-
背景
-
Synonyms: DKFZp564O1863, FGFR1 oncogene partner 2, HSPC123, HSPC123 like, FGOP2_HUMAN.
Background: FGFR1OP2 belongs to the SIKE family. The FGFR1OP2 (FGFR1 oncogene partner 2) gene was identified through its involvement in a fusion with the FGFR1 gene. FGFR1OP2 may be involved in the wound healing pathway. It is expressed in bone marrow, spleen and thymus. A chromosomal aberration involving FGFR1OP2 may be a cause of stem cell myeloproliferative disorder (MPD). Insertion ins(12,8)(p11,p11p22) with FGFR1. MPD is characterized by myeloid hyperplasia, eosinophilia and T cell or B cell lymphoblastic lymphoma. In general it progresses to acute myeloid leukemia. The fusion protein FGFR1OP2-FGFR1 may exhibit constitutive kinase activity and be responsible for the transforming activity.
-
基因ID
- 26127
抗原
-
